Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Prof Ulrich Reininghaus
+4962117031930
ulrich.reininghaus@zi-mannheim.de


Dr Anita Schick
+4962117031941
anita.schick@zi-mannheim.de


More information about this study, what is involved and how to take part can be found on the study website.

Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Implementing digital mobile mental health in routine care
Back

Implementing digital mobile mental health in routine care

Not Recruiting

Open to: All Genders

Age: Mixed

Mannheim Wiesloch Kortenberg Bierbeek Edinburgh Bratislava Kosice

Medical Conditions

Mental disorders

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


Digital technology provides a unique opportunity to involve service users in their clinical care. Digital Mobile Mental Health (DMMH) is an innovative, evidence-based digital health tool, which is based on the Experience Sampling Method, a method similar to that of a structured daily diary. It offers the opportunity for service users to be at the center of their therapy by providing patients the ability to be more involved in the shaping of their therapy goals, as well as the opportunity to lead discussions with their clinicians about their complaints, recovery, and well-being. As part of the Implementing Mobile MEntal health Recording Strategy for Europe (IMMERSE) consortium, we aim to evaluate the implementation of the DMMH tool into routine mental health care in 4 countries in Europe.

DMMH is a web- and app-based software system that consists of a health app (the “MoMent app”) that lets users of mental health services document how they feel throughout the day. With this app, service users together with their practitioners can view the information collected, discuss and use a secure feedback website (the “MoMent dashboard”) to better understand their treatment and condition.

In addition to this, we want to identify key aspects which contribute to the successful and effective implementation of the DMMH in routine mental health care. We will do this by talking to, and observing, service users and clinicians. We aim to establish what works, for whom, in what circumstances, in what respects, to what extent, and why.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

01 Nov 2022 30 Jun 2024

Publications

2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38915006/ (added 25/06/2024)

In this clinical trial, the use of the MoMent app in conjunction with standard care will be compared to standard care without app use. Participants will either have the opportunity to use the MoMent app or not based on which clinical unit they are admitted to. Clinical units will be allocated to either the experimental group or the control group, with an equal chance of being in either group (like tossing a coin). Participants and researchers will not have a choice in the treatment given. The participants admitted to clinical units which are allocated to the experimental group will have the opportunity to use the MoMent app for a maximum period of 6 months, which will be offered to service users by the clinician in charge of their treatment (i.e. psychiatrists, psychologists, specialist mental health nurses, or other key workers) during their admission. During the intervention period, participants using the MoMent app will be asked a range of questions daily related to mental health symptoms, mood, current activity, and social activity. These can be chosen by the clinician alongside the participant. In the first 2 months, various implementation strategies will be provided including a manual. The participants admitted to clinical units which are allocated to the control group will receive their standard treatment as usual.

The study will consist of one baseline and three follow-up assessments conducted by the research team who will not be aware of whether a participant/clinician is in the control or experimental condition. The baseline assessment will involve a phase of 6 consecutive days of ESM monitoring and the completion of questionnaires. Follow-up assessments will be completed at 2, 6, and 12 months post-baseline.


Help-seeking service users and clinicians in charge of their treatment within the mental health services at the participating clinical units and their care pathways will be eligible.

You can take part if:



You may not be able to take part if:


Service users:1. Evidence that psychiatric symptoms are precipitated by an organic cause (incl. a diagnosis of ICD-10 F00-F09)2. Significant risk to themselves or others3. Clinical diagnosis of intellectual disability (ICD-10 F70-79) or disorders of psychological development (ICD-10 F80-89) that are sufficiently severe to impair a person’s ability to provide informed consent4. Medical or psychological contra-indication (as judged by the clinician in charge)5. Self-reported inability or unwillingness to use a smartphone to collect ESM data 6. Not fluent and literate in German (Germany), Dutch (Belgium), Slovak (Slovakia), or English (Scotland)7. Short life expectancy/terminal illness


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Central Institute of Mental Health
    J 5
    Mannheim
    68159
  • Psychiatric Centre Nordbaden
    Heidelberger Str. 1a
    Wiesloch
    69168
  • KU Leuven University Hospital UZ Leuven
    Leuvensesteenweg 517
    Kortenberg
    3070
  • Psychiatric Hospital Sint-Kamillus
    Zorggroep Sint-Kamillus Krijkelberg 1
    Bierbeek
    3360
  • Lothian Mental Health Service
    Lothian Child and Mental Health Service Royal Edinburgh Hospital 23 Tipperlinn Rd
    Edinburgh
    EH105HF
  • Psychiatric Clinic of Faculty of Medicine and University Hospital Bratislava
    Hospital Staré Mesto Mickiewiczova 13
    Bratislava
    81369
  • Faculty of Medicine, PJ Safarik University in Kosice
    Trieda SNP 1
    Kosice
    04011

There are no direct benefits to participants from participating in this study. However, this study is important because it aims to improve our understanding of how the MoMent app and similar technologies can best be used to help people with mental health problems and those who treat them. Smartphone apps for monitoring mood and mental health have been used in research for about 20 years. The use of these technologies has been shown to be feasible in different patient groups and no worsening of complaints occurred. The risk of adverse effects or discomfort is very low.

Prof Ulrich Reininghaus
+4962117031930
ulrich.reininghaus@zi-mannheim.de


Dr Anita Schick
+4962117031941
anita.schick@zi-mannheim.de



More information about this study, what is involved and how to take part can be found on the study website.


The study is sponsored by Central Institute of Mental Health and funded by Horizon 2020.



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: ISRCTN15109760

Or CPMS 53732

Last updated 25 June 2024

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top